Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Meningioma 3 Brain Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Radiation Injuries 2 Pituitary Neoplasms 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Wilms Tumor 1 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Resectable Lung Non-Small Cell Carcinoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neurilemmoma 1 Neoplasms, Adipose Tissue 1 Nasopharyngeal Carcinoma 1 Myoepithelioma 1 Mesothelioma, Malignant 1

Interventions

Cyclophosphamide 13 pembrolizumab 8 Brentuximab Vedotin 8 fludarabine 7 Nivolumab 7 Whole-Body Irradiation 6 Specimen Handling 6 Mycophenolic Acid 6 Gemcitabine 6 Etoposide 6 Doxorubicin 6 Dacarbazine 6 fludarabine phosphate 5 Vinblastine 5 Melphalan 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Dexamethasone 5 Stem Cell Transplantation 4 Cytarabine 4 Vinorelbine 3 Tacrolimus 3 Magnetic Resonance Spectroscopy 3 Cyclosporine 3 Carmustine 3 Blood Specimen Collection 3 thymoglobulin 2 polatuzumab vedotin 2 pegylated granulocyte colony-stimulating factor 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hodgkin Disease × Proton Therapy × Clear all

NCT06883604 2025-03-19

PRO-Hodgkin

Uppsala University Hospital

Phase NA Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡